A novel regimen of doravirine and islatravir was noninferior to a common HIV therapy as an initial HIV treatment, according ...
A key opinion leader reviews findings presented at ID Week 2020 from a post-hoc analysis of the AMBER study comparing GI tolerability of D/C/F/TAF to TDF. Moti Ramgopal, MD, FACP, FIDSA, CPI: The ...
We conducted a phase 3, double-blind, randomized, controlled trial involving adolescent girls and young women in South Africa and Uganda. Participants were assigned in a 2:2:1 ratio to receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results